Abatacept as GVHD Prophylaxis Phase 2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leslie Kean, MD, PhD
Boston Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S and Women'S Health Center of Bc
Vancouver, British Columbia, Canada
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida
Gainesville, Florida, United States
- Children'S Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
- Emory University/winship Cancer Center
Atlanta, Georgia, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Michael Grimley
Cincinnati, Ohio, United States
- University of Utah
Salt Lake City, Utah, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Feb 2013
- Primary completion
- 30 Jun 2018
- Completion
- 30 Mar 2024
- Last update posted
- 11 Dec 2025
- Registered enrollment
- 186
- Registry id
- NCT01743131
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.